Raffles Medical Group
Raffles Medical Group is a private healthcare provider in Asia, operating medical facilities in thirteen cities in Singapore, China, Japan, Vietnam and Cambodia.
See below for the Latest Raffles Medical Group News, Analysis, Profit Results, Share Price Information, and Commentary.
Raffles Medical Group’s profit falls 67.4% YoY top $12.4m in 3Q23
Year-to-date, the company’s profit has declined 25.6% YoY.
Raffles Medical Group’s profit falls 67.4% YoY top $12.4m in 3Q23
Year-to-date, the company’s profit has declined 25.6% YoY.
Raffles Medical Group’s PATMI rises slightly by 0.5% YoY to $59.9m in 1H23
Its revenue, however, fell by 9.5% YoY.
Raffles Medical’s profit after tax soars 71.7% YoY to $143.7m in FY22
The company attributed the increase to the return of foreign patients.
Raffles Medical Group to get higher margins amidst China reopening
Elective surgery revival will benefit the hospital group.
After mitigating cost pressures, Raffles Medical records 62.1% net profit growth
One of the biggest medical groups posted a net profit of $38.3m.
Raffles Medical Group to get positive contribution from China operations: analyst
Its target price was at $1.60.
Raffles Medical H1 profit surges 54.4%Â
Patient numbers had increased on the back of recovering medical tourism.
Raffles Medical Group to see a 10% decline in H122 net profit: forecast
This is on the back of expected lower revenue from the hospital's COVID-19 services.
Raffles Medical Group earnings per share estimate cut by 8-12% for FY22/24
Maybank Securities Research cited two reasons for its lower estimate.
Raffles Medical Group’s H2 2021 net profit declines 7.2% to $44.88m
This is despite a 16.3% increase in its revenue during the same period.
STI to reach 3,500 in 2022: UOB Kay Hian
The bullish forecast is attributed to the strong GDP growth in 2021.
Raffles Medical set to profit from the opening of SIngapore’s borders - RHB
The company is the sole provider of Covid-19 PCR tests for Changi Airport.Â
Raffles Medical faces an upward trend in 2022F
This is due to the planned reopening of Singapore’s borders and economy.
Â
In a report by RHB, Raffles Medical (RFMD) is predicted to have an upward trend for the financial year 2022.
Raffles Medical Group revenue surges to $343.8m in H1
The group’s profits after tax ballooned by as much as 138.4%.
IP coverage extended to COVID vaccines under WHO's special access route
It will apply to vaccines administered in Singapore under SAR.
Mary Khoo Ngah Im joins Raffles Medical Group as company secretary
She held executive positions in non-governmental organisations in China from 2004 to 2013.